Medication Administration and Blood Glucose Monitoring Deficiencies
Summary
The facility failed to ensure that residents received medications in a timely manner according to physician's orders, affecting two residents. One resident, who was moderately cognitively impaired and had a history of cerebral palsy, quadriplegia, and neuropathy, did not receive prescribed doses of gabapentin and baclofen on multiple occasions due to the medications being on order. The facility's staff did not document any contact with the resident's provider regarding the missed doses, and the Director of Nursing (DON) confirmed the absence of such documentation. The DON acknowledged that the medications were crucial for managing the resident's nerve pain and muscle spasms, and that inconsistent administration could reduce their effectiveness. Another resident, who was cognitively intact and had chronic respiratory failure and anxiety disorder, also missed doses of prescribed medications, including buspirone and Advair, due to them being on order. The facility's staff failed to document any communication with the resident's provider about the missed doses. The DON verified the missed doses and expressed confusion over the documentation, as some doses were marked as administered despite the medications being unavailable. The resident's conditions required consistent medication administration to manage anxiety and respiratory issues. Additionally, the facility failed to use appropriate devices for blood glucose monitoring for four residents. Due to a shortage of lancets, the facility resorted to using insulin syringes with needles to obtain blood samples, which was more painful for the residents. The Assistant Director of Nursing (ADON) directed this practice, and the DON confirmed it was inappropriate. Residents reported increased pain from the needle method, and the Medical Director noted that while it caused more discomfort, there were no long-term consequences. The facility's supply management issues led to the use of inappropriate devices for blood glucose testing.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.